What every woman should know about menopause and heart health
Heart disease is the leading cause of death for women in the U.S., yet most doctors wait until cholesterol reaches dangerous levels to treat it. That can mean missing the silent cardiovascular shifts that begin years earlier — often during perimenopause.
As explains below, that’s why perimenopause is increasingly viewed as a critical “window of opportunity” to protect heart health. A in the Journal of the American Heart Association found that perimenopausal women were twice as likely to have lower measures of cardiovascular health as women with regular menstrual cycles.
Before menopause, from the blood, keeps blood vessels healthy, maintains insulin sensitivity, and regulates inflammation — all of which support heart health. When and then plummet after menopause, those protections erode, even as a basic cholesterol panel continues to stay within a normal range.
How Declining Estrogen Affects the Heart
Estrogen protects the heart across multiple pathways, which is what makes its loss during menopause so destabilizing.
Cholesterol and blood vessels
HDL cholesterol (the “good” kind) carries excess cholesterol to the liver for disposal. Estradiol, the main form of estrogen, helps regulate both the amount of HDL in the blood and how well it works. As estradiol falls, HDL particles can become smaller and less effective, even if fall within .
At the same time, LDL (the “bad” cholesterol) and ApoB, which reflects the number of plaque-forming particles in the blood, in the year before and . So now you’ve got more bad cholesterol and fewer good particles to effectively clear it.
Blood vessels may also become stiffer, making it easier for plaque to build. A study of more than 52,000 women linked estrogen loss during menopause with .
Abdominal fat and blood sugar
Before menopause, estrogen helps direct fat to the hips and thighs. As estrogen declines, , where it’s more harmful for the heart.
The found that , the deeply embedded fat surrounding the internal organs, begins accumulating faster in the two years before the final . It rises from roughly 5%–8% of total body fat before menopause to . has linked this buildup to increased plaque in the arteries supplying the brain, raising the risk of heart disease and stroke.
Estrogen also helps cells respond to insulin and. As estrogen falls, insulin resistance may increase, raising the risk of high blood pressure, and .
Blood pressure and inflammation
·ˇ˛őłŮ°ů´Ç˛µ±đ˛Ô’s help keep blood vessels healthy and blood pressure stable. As it declines, may rise.
Inflammation makes arteries thicker, stiffer, and more likely to accumulate plaque, while forces the heart to work harder. Over time, both can .
Blood clotting
Estrogen also helps regulate the platelets that form blood clots. As estrogen declines, the clotting system may become . A clot that forms on arterial plaque can block blood flow to the heart or brain, causing a heart attack or stroke.
These shifts may help explain why in women between their late forties and early sixties.
Heart Health Tests to Ask About in Midlife
A standard cholesterol panel is a useful starting point, but it may not tell the whole story. Ask your doctor whether you also need:
- Lipoprotein(a). This genetic marker, which you need to check only once, measures a sticky, inflammation-promoting form of LDL that independently raises risk for heart disease and stroke. after menopause by , but can be lowered with hormone therapy.
- Hematocrit. This marker measures the proportion of red blood cells in the blood. Higher levels mean thicker blood. Elevated hematocrit can signal reduced circulation efficiency and increased clotting risk.
- Blood pressure. Sustained increases over time, even within the normal range, can suggest blood vessel stiffening and warrant deeper cardiac evaluation.
- and duration. Women whose across four or more annual checkups have a measurably . have linked persistent hot flashes to stiffer arteries, which often lead to plaque buildup.
Measuring estrogen itself generally does not reveal a woman’s heart risk. Levels fluctuate widely during perimenopause, and women with similar estrogen levels can have very different heart risks depending on their age, genetics, health history, and lifestyle.
Can HRT Help Protect Heart Health?
For many women, to levels that significantly reduce the factors driving heart disease, particularly when initiated at the right time and under the right conditions. Benefits may depend on these factors:
Timing
The cardiovascular risk-benefit profile is generally most favorable when HRT is started or within 10 years of menopause. In the large-scale , women ages 50–59 who received estrogen-only HRT had a than those who received a placebo.
After age 60, the risk-benefit equation shifts, , which is why decisions made later require more individualized assessment.
Type of HRT
The formulation of HRT affects how estradiol is metabolized and the risks it carries. passes through the liver and can increase triglycerides and clotting factors in some women. Transdermal estrogen — delivered through a , gel, or — bypasses the liver and may offer a more favorable clotting profile for some patients.
Whether a woman needs estrogen alone or also depends on her health history and whether she has a uterus. A clinician can help determine the safest option.
Your health history
HRT requires individualized guidance if you have a history of:
- Breast cancer or another
- Blood clots or a clotting disorder
- History of stroke, heart attack, or cardiovascular disease
- Liver or gallbladder disease
Some women with these conditions may still have , but the decision should be made with a clinician familiar with their history.
A Smarter Approach to Midlife Heart Health
Hone-affiliated physicians recommend going to assess whether estrogen loss is affecting arterial inflammation, , liver function, and hormones together.
If HRT is appropriate, treatment should be matched to the patient’s symptoms, health history, test results, and stage of menopause. But hormones are only one part of the picture. , aerobic activity, sleep quality, and all directly influence ApoB, blood pressure, and , the same markers driving cardiovascular risk.
was produced by and reviewed and distributed by ±¬ÁĎTV.
